ReviewFrontiers in plant science2025
Functional phytochemicals in tomatoes: biosynthesis, gene regulation, and human health implications.
Review in Frontiers in plant science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Solid-State Fermentation byMolecules (Basel, Switzerland) · 2026Article
- Biological Control of Tomato Root Rot Caused byJournal of fungi (Basel, Switzerland) · 2026Review
Corrections and comments
- Erratum issued
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The nutritional and health-promoting properties of tomatoes (Solanum lycopersicum), a highly significant crop, are attributed to their abundance of beneficial components, such as flavonoids, phenolic compounds, and carotenoids (including lycopene and β-carotene). The occurrence of these bioactive molecules is influenced by genetic, environmental, and agronomic factors, with ripening playing a critical role in their accumulation. This abstract delves into the molecular machinery controlling phytochemical accumulation, with a specific focus on the regulation of lycopene biosynthesis. The RIPENING-INHIBITOR (RIN) transcription factor, a master regulator of fruit maturation, exerts direct control over lycopene accumulation by binding to the promoters of critical biosynthetic genes. RIN directly activates the expression of PHYTENE SYNTHASE 1 (PSY1), the key rate limiting enzyme committing metabolic flux to the carotenoid pathway, and PDS, encoding phytocene desaturase, thereby orchestrating the massive lycopene synthesis characteristic of the ripening transition. Strategies for the biofortification of tomato fruits have leveraged this understanding through targeted genetic manipulation. Overexpression of key enzymes, such as the bacterial CrtB (phytoene synthase) or manipulation of the endogenous PSY1, has successfully enhanced lycopene flux. More profoundly, the manipulation of transcription factors offers a powerful multi-gene approach. For instance, the overexpression of fruit-specific promoters driving RIN or other regulators like HYR (High Pigment) can simultaneously improve the entire pathway, leading to substantial increases in lycopene content. Flavonoids and phenolic compounds are produced by the phenylpropanoid pathway, which is regulated by enzymes such as chalcone synthase (CHS) and phenylalanine ammonialyase (PAL). Gene regulation of these pathways involves a complex interplay of transcription factors (e.g., RIN, NOR, and HY5) and phytohormones (e.g., ethylene and abscisic acid), which modulate expression patterns during fruit development and stress responses. Phytochemical levels are also significantly influenced by environmental factors; for instance, optimal lycopene synthesis occurs at 20-25 °C, while higher temperatures above 30 °C inhibit lycopene accumulation and promote beta-carotene synthesis, a shift mediated by the temperature-sensitive expression of key genes, including those regulated by RIN. Naturally occurring or induced mutations in genes such as DET1 and HP2, which are negative regulators of light signal transduction, result in high pigment phenotypes with dramatically increased lycopene and flavonoid content. The successful application of metabolic engineering and transcription factor manipulation for biofortification holds immense promises for developing next-generation tomato cultivars with amplified health-promoting properties, directly linking agricultural science to improved human health outcomes through the mitigation of chronic diseases like cancer and cardiovascular disorders.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.